A Trial of the ALK Grass Tablet in Subjects With Hayfever

NCT00227279 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
634
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ALK-Abelló A/S